Mutual of America Capital Management LLC Reduces Stake in Pediatrix Medical Group, Inc. $MD

Mutual of America Capital Management LLC lowered its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 12.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,818 shares of the company’s stock after selling 1,491 shares during the period. Mutual of America Capital Management LLC’s holdings in Pediatrix Medical Group were worth $155,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC boosted its stake in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after buying an additional 1,765 shares during the period. Marshall & Sullivan Inc. WA purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter worth about $41,000. AlphaQuest LLC boosted its stake in shares of Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock worth $85,000 after purchasing an additional 811 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new position in shares of Pediatrix Medical Group during the 1st quarter worth about $159,000. Finally, Optimize Financial Inc purchased a new position in shares of Pediatrix Medical Group during the 1st quarter worth about $167,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on MD shares. Zacks Research cut Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 4th. Truist Financial set a $17.00 price target on Pediatrix Medical Group in a report on Tuesday, October 14th. Finally, Leerink Partners boosted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus target price of $16.93.

Pediatrix Medical Group Trading Down 2.9%

Pediatrix Medical Group stock opened at $17.36 on Friday. The stock has a market cap of $1.51 billion, a PE ratio of 13.46 and a beta of 1.26. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The stock has a 50-day moving average of $16.84 and a two-hundred day moving average of $14.79. Pediatrix Medical Group, Inc. has a one year low of $11.84 and a one year high of $18.22.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. Pediatrix Medical Group’s revenue was down 7.1% on a year-over-year basis. During the same period last year, the firm posted $0.34 EPS. On average, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.